Home > Annual Financials > GENNEX LABORATORIES

GENNEX LABORATORIES Financial Statement Analysis
[BOM: 531739]

The Revenues of GENNEX LABORATORIES have increased by 59.03% YoY .
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 7.50 % YoY.
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Annual Financial Results
[BOM: 531739]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹138 Cr₹87 Cr₹66 Cr₹61 Cr₹60 Cr
Expenses ₹121 Cr₹70 Cr₹61 Cr₹56 Cr₹53 Cr
Operating Profit (Excl OI) ₹17 Cr₹17 Cr₹4.69 Cr₹5.38 Cr₹6.53 Cr
Other Income ₹10 Cr₹4.91 Cr₹3.95 Cr₹1.38 Cr₹0.52 Cr
Interest ₹3.61 Cr₹3.08 Cr₹1.35 Cr₹0.88 Cr₹0.74 Cr
Depreciation ₹1.99 Cr₹2.37 Cr₹0.92 Cr₹0.79 Cr₹0.88 Cr
Profit Before Tax ₹21 Cr₹16 Cr₹6.37 Cr₹5.09 Cr₹5.06 Cr
Profit After Tax ₹18 Cr₹13 Cr₹4.92 Cr₹3.92 Cr₹4.04 Cr
Consolidated Net Profit ₹18 Cr₹11 Cr₹6.19 Cr₹4.11 Cr₹4.04 Cr
Earnings Per Share (Rs)₹0.86₹0.80₹0.50₹0.35₹0.32
PAT Margin (%)10.6511.6013.406.856.01
ROE(%)10.4010.4910.777.959.39
ROCE(%)10.7012.4913.6410.1911.82
Total Debt/Equity(x)0.360.130.120.220.23

Key Financials

Market Cap : ₹ 208.7 Cr
Revenue (TTM) : ₹ 183.1 Cr
Net Profit(TTM) : ₹ 20.6 Cr
EPS (TTM) : ₹ 0.8
P/E (TTM) : 10.1

Industry Peers & Returns1W1M1Y
GENNEX LABORATORIES -4.2% -16.8% -38%
SUN PHARMACEUTICAL INDUSTRIES -0.1% -6.5% 3.8%
DIVIS LABORATORIES -0.2% -5.5% 35.7%
TORRENT PHARMACEUTICALS 0.4% -8.2% 25.2%
CIPLA 1.7% -2% -15.3%
DR REDDYS LABORATORIES 4.9% 7.7% -2.5%
MANKIND PHARMA 2.2% -6.5% -10.5%
LUPIN -0.2% -7.1% -0.7%
ZYDUS LIFESCIENCES 4.1% -1% 14.2%


GENNEX LABORATORIES Revenues
[BOM: 531739]

Y-o-Y

59.03 %

5 Yr CAGR

23.31 %

Years Revenues % Change
Mar2026 ₹138 Cr
59.03
Mar2025 ₹87 Cr
32.18
Mar2024 ₹66 Cr
7.17
Mar2023 ₹61 Cr
2.62
Mar2022 ₹60 Cr -


GENNEX LABORATORIES Operating Profit
[BOM: 531739]

Y-o-Y

-1.97 %

5 Yr CAGR

26.44 %

Years Operating Profit % Change
Mar2026 ₹17 Cr
-1.97
Mar2025 ₹17 Cr
262.88
Mar2024 ₹4.69 Cr
-12.74
Mar2023 ₹5.38 Cr
-17.68
Mar2022 ₹6.53 Cr -

Operating Margins
Y-o-Y

-38.34 %

5 Yr CAGR

2.55 %

Years Operating Margin% % Change
Mar2026 12.11%
-38.34
Mar2025 19.64%
174.69
Mar2024 7.15%
-18.66
Mar2023 8.79%
-19.73
Mar2022 10.95% -

GENNEX LABORATORIES Profit After Tax
[BOM: 531739]

Y-o-Y

59.35 %

5 Yr CAGR

45.55 %

Years Profit After Tax % Change
Mar2026 ₹18 Cr
59.35
Mar2025 ₹11 Cr
83.61
Mar2024 ₹6.19 Cr
50.89
Mar2023 ₹4.11 Cr
1.66
Mar2022 ₹4.04 Cr -

PAT Margins
Y-o-Y

-8.19 %

5 Yr CAGR

15.38 %

Years PAT Margin(%) % Change
Mar2026 10.65 %
-8.19
Mar2025 11.6 %
-13.43
Mar2024 13.4 %
95.62
Mar2023 6.85 %
13.98
Mar2022 6.01 % -

GENNEX LABORATORIES Earnings Per Share (EPS)
[BOM: 531739]

Y-o-Y

7.50 %

5 Yr CAGR

28.04 %

Years EPS % Change
Mar2026 ₹0.86
7.50
Mar2025 ₹0.80
60.00
Mar2024 ₹0.50
42.86
Mar2023 ₹0.35
9.37
Mar2022 ₹0.32 -

GENNEX LABORATORIES Return on Capital Employed (ROCE)
[BOM: 531739]

Y-o-Y

-14.33 %

5 Yr CAGR

-2.46 %

Years ROCE % Change
Mar2026 10.7%
-14.33
Mar2025 12.49%
-8.43
Mar2024 13.64%
33.86
Mar2023 10.19%
-13.79
Mar2022 11.82% -

GENNEX LABORATORIES Share Price vs Sensex

Current Share Price : ₹8.6
Current MarketCap: ₹ 208.7 Cr
Updated EOD on :Oct 26,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-4.2%

-16.8%

-38%

SENSEX

-1.5%

-1.2%

-11.8%

GENNEX LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.9% -7.5% 7%
No NSE index found

You may also like the below Video Courses


FAQ about GENNEX LABORATORIES Financials


How the annual revenues of GENNEX LABORATORIES have changed ?

The Revenues of GENNEX LABORATORIES have increased by 59.03% YoY .

How the Earnings per Share (EPS) of GENNEX LABORATORIES have changed?

The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 7.50 % YoY .